Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

RUN

Analyzing the Surge – A Closer Look at RUN Stock Performance

Shares of Sunrun rose to $19.32 during today's afternoon trading session. Despite the 1.1% change, the Mid-Cap Solar company still trades 12.43% above its average analyst target price of $17.18. So there may be further downside for the Solar stock. Sunrun has target prices ranging from $10.0 to $25.0 per share, and its average rating is buy.

The stock has an unusually large proportion of its shares sold short at 31.0%, and a short ratio of 3.56. Since 3.28% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 104.9% of Sunrun's shares being owned by this investor type.

Institutions Invested in Sunrun

Date Reported Holder Percentage Shares Value
2025-06-30 Blackrock Inc. 16% 37,300,822 $720,651,869
2025-06-30 Vanguard Group Inc 10% 23,904,225 $461,829,619
2025-06-30 Greenvale Capital, LLP 6% 13,700,000 $264,683,995
2025-06-30 Dimensional Fund Advisors LP 5% 10,986,570 $212,260,529
2025-06-30 Point72 Asset Management, L.P. 5% 10,663,538 $206,019,550
2025-06-30 Grantham, Mayo, Van Otterloo & Co. LLC 5% 10,617,456 $205,129,246
2025-06-30 State Street Corporation 4% 9,320,648 $180,074,916
2025-06-30 Maple Rock Capital Partners, Inc. 4% 8,132,648 $157,122,756
2025-06-30 PGGM Investments 3% 7,007,258 $135,380,222
2025-06-30 Geode Capital Management, LLC 2% 5,440,575 $105,111,907

Besides an analyst belief that shares are overpriced, other market factors point to there being negative market sentiment on Sunrun.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS